HM
CRL icon

HealthCor Management’s Charles River Laboratories CRL Stock Holding History

HealthCor Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-107,800
Closed -$26.9M – 89
2020
Q4 		$26.9M Sell
107,800
-134,430
-55% -$32M 1.04% 34
2020
Q3 		$54.9M Buy
242,230
+141,500
+140% +$29.4M 2.2% 21
2020
Q2 		$17.6M Sell
100,730
-483,890
-83% -$77.2M 0.74% 34
2020
Q1 		$73.8M Buy
584,620
+409,620
+234% +$61.4M 3.15% 12
2019
Q4 		$26.7M Sell
175,000
-190,360
-52% -$26.4M 0.95% 39
2019
Q3 		$48.4M Buy
365,360
+947
+0.3% +$127K 1.83% 22
2019
Q2 		$51.7M Buy
+364,413
New +$49.4M 2.01% 21

Other funds holding CRL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return